418 JOURNAL OF CHEMICAL RESEARCH 2013
5H), 7.83 (m, 2H), 7.92 (d, J = 7.2 Hz, 1H), 8.03 (d, J = 7.2 Hz,
1H). 13C NMR (100 MHz, CDCl3): δ 34.7, 40.4, 120.9, 125.1, 126.8,
127.3, 128.6, 128.9, 134.3, 134.7, 137.4, 137.7, 158.6.
the O-alkylated isomer exclusively, we also examined the
highly hindered t-butanol as alkylating agent. Unfortunately,
no product was observed perhaps due to the bulkiness of
t-butanol. In all the cases listed in Table 1, the products were
easily purified by column chromatography on silica gel and
were characterised on the basis of physical and spectroscopic
data and also by comparison with authentic samples.5,7–10
In conclusion, we have systematically examined the alkyla-
tion of saccharin with various alcohols under Mitsunobu con-
ditions. It was found for the first time that the regioselectivity
for the N/O-alkylation in this protocol is clearly determined by
steric effects wherein the less sterically hindered alcohols tend
to favour the N-alkylation and vice versa. This protocol has
several advantages, such as mild reaction conditions, good
product yields, simplicity in operation and easy availability
of the substrates. Thus, we believe that this methodology will
offer an important complement to the reported methods for
alkylation of saccharin and will further expand the utilities of
saccharin in the field of synthetic and medicinal chemistry.
3-(2-Phenylethyloxy)-1,2-benzisothiazole 1,1-dioxide: Colourless
1
oil; H NMR (400 MHz, CDCl3): δ 3.20 (t, J = 6.8 Hz, 2H), 4.78 (t,
J = 6.8 Hz, 2H), 7.29 (m, 5H), 7.73 (m, 3H), 7.86 (d, J = 7.2 Hz, 1H).
13C NMR (100 MHz, CDCl3): δ 34.6, 72.1, 121.8, 123.2, 126.9, 127.0,
128.7, 128.9, 133.4, 134.0, 136.4, 143.5, 169.0; HRMS Calcd for
C15H14NO3S [M+H]+: 288.0689. Found: 288.0683.
2-Butyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless solid,
m.p. 38–40 °C (lit.9 39–40 °C); 1H NMR (400 MHz, CDCl3): δ 0.91 (t,
J = 7.2 Hz, 3H), 1.37 (m, 2H), 1.77 (m, 2H), 3.71 (t, J = 7.6 Hz, 2H),
7.78 (m, 3H), 7.97 (dd, J = 6.8, 1.6 Hz, 1H). 13C NMR (100 MHz,
CDCl3): δ 13.3, 19.8, 30.2, 38.9, 120.6, 124.8, 127.2, 134.1, 134.5,
137.5, 158.7.
3-Butyloxy-1,2-benzisothiazole 1,1-dioxide: Colourless solid, m.p.
1
94–96 °C; H NMR (400 MHz, CDCl3): δ 0.98 (t, J = 7.2 Hz, 3H),
1.48 (m, 2H), 1.86 (m, 2H), 4.58 (t, J = 6.8 Hz, 2H), 7.73 (m, 3H),
7.85 (d, J = 7.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 13.5, 18.9,
30.2, 72.0, 121.7, 123.2, 127.0, 133.4, 134.0, 143.5, 169.2; HRMS
Calcd for C11H14NO3S [M+H]+: 240.0689; found: 240.0695.
2-Octyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless oil10;
1H NMR (400 MHz, CDCl3): δ 0.86 (t, J = 6.8 Hz, 3H), 1.35 (m,
10H), 1.84 (m, 2H), 3.75 (t, J = 7.2 Hz, 2H), 7.84 (m, 3H), 8.04 (d,
J = 7.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 14.0, 22.6, 26.8, 28.4,
28.9, 29.0, 31.7, 39.4, 120.8, 125.0, 127.4, 134.2, 134.6, 137.7, 158.9;
HRMS Calcd for C15H22NO3S [M+H]+: 296.1315; found: 296.1309.
3-Octyloxy-1,2-benzisothiazole 1,1-dioxide: Colourless oil; 1H NMR
(400 MHz, CDCl3): δ 0.84 (t, J = 6.8 Hz, 3H), 1.36 (m, 10H), 1.84 (m,
2H), 4.53 (t, J = 6.8 Hz, 2H), 7.69 (m, 3H), 7.81 (d, J = 7.2 Hz, 1H).
13C NMR (100 MHz, CDCl3): δ 13.8, 22.4, 25.5, 28.1, 28.9, 31.5,
72.1, 121.5, 123.2, 126.8, 133.3, 133.9, 143.3, 169.0; HRMS Calcd
for C15H22NO3S [M+H]+: 296.1315; found: 296.1326.
Experimental
Reagents and solvents were all from commercial sources and were
used without further purification. 1H NMR and 13C NMR spectra were
recorded on a Mercury Plus 400 MHz spectrometer. Chemical shifts
were reported relative to internal tetramethylsilane (δ 0.00 ppm) or
CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. Melting
points were measured on a Kofler apparatus and uncorrected. Column
chromatography was performed on 200–300 mesh silica gel. Analyti-
cal TLC was performed on silica gel GF254 plates. HRMS were recorded
on a Bruker Daltonics APEX II 47e spectrometer.
2-Dodecyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless
Alkylation of saccharin under Mitsunobu conditions, general
procedure:
1
solid, m.p. 49–51 °C (lit.9 48–50 °C); H NMR (400 MHz, CDCl3):
δ 0.88 (t, J = 6.6 Hz, 3H), 1.34 (m, 18H), 1.85 (m, 2H), 3.77 (t, J =
7.6 Hz, 2H), 7.84 (m, 2H), 7.92 (d, J = 7.6 Hz, 1H), 8.05 (d, J =
7.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 14.1, 22.6, 26.8, 28.4,
29.0, 29.3, 29.4, 29.5, 29.6, 31.9, 39.5, 120.8, 125.0, 127.5, 134.2,
134.6, 137.7, 158.9.
Diisopropyl azodicarboxylate (DIAD, 4.5 mmol) was placed in a
50 mL round-bottomed flask equipped with a stirring bar. Then triphe-
nylphosphine (Ph3P, 4.5 mmol) and dry tetrahydrofuran (THF, 20 mL)
were added and the solution was cooled in an ice bath. Then the alco-
hol (3.0 mmol) was added. The mixture was then stirred for 10 min
and a solution of saccharin (3.0 mmol) in dry THF (5 mL) was added
dropwise. After being stirred for 30 min, the flask was removed from
the ice bath and the solution was stirred at room temperature, and
monitored by TLC. When the reaction was judged to be complete, the
organic solvent was evaporated under reduced pressure. The residue
was purified by column chromatography on silica gel using petroleum
ether/EtOAc (v/v = 10:1) as the eluent to give the products. All the
isolated products were characterised by physical and spectroscopic
data and also by comparison with authentic samples.5,7–10 The physical
and spectral data of the products are shown as follows.
3-Dodecyloxy-1,2-benzisothiazole 1,1-dioxide: Colourless solid,
1
m.p. 54–55 °C; H NMR (400 MHz, CDCl3): δ 0.88 (t, J = 6.4 Hz,
3H), 1.39 (m, 18H), 1.89 (m, 2H), 4.59 (t, J = 6.8 Hz, 2H), 7.73 (m,
3H), 7.88 (d, J = 7.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 14.0,
22.6, 25.6, 28.2, 29.1, 29.2, 29.4, 29.5, 29.6, 31.8, 72.3, 121.8, 123.2,
127.1, 133.3, 134.0, 143.5, 169.2; HRMS Calcd for C19H30NO3S
[M+H]+: 352.1941; found: 352.1933.
2-Benzyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless
solid, m.p. 108–110 °C (lit.5 108–110 °C); 1H NMR (400 MHz,
CDCl3): δ 4.91 (s, 2H), 7.33 (m, 3H), 7.51 (d, J = 7.2 Hz, 2H), 7.84
(m, 2H), 7.93 (d, J = 7.6 Hz, 1H), 8.05 (d, J = 6.8 Hz, 1H). 13C NMR
(100 MHz, CDCl3): δ 42.9, 121.3, 125.5, 127.5, 128.5, 128.9, 129.0,
134.6, 134.7, 135.0, 138.0, 159.1.
2-Methyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless solid,
1
m.p. 132–133 °C (lit.7 129–130 °C); H NMR (400 MHz, CDCl3):
δ 3.26 (s, 3H), 7.83 (m, 2H), 7.93 (dd, J = 7.2, 1.6 Hz, 1H), 8.05 (dd,
J = 7.2, 1.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 23.2, 120.9,
125.1, 127.5, 134.3, 134.6, 137.5, 158.6.
3-Benzyloxy-1,2-benzisothiazole 1,1-dioxide: Colourless solid,
1
m.p. 131–133 °C (lit.5 128–129 °C); H NMR (400 MHz, CDCl3):
δ 5.59 (s, 2H), 7.47 (m, 5H), 7.74 (m, 3H), 7.88 (d, J = 7.6 Hz, 1H).
13C NMR (100 MHz, CDCl3): δ 73.5, 121.9, 123.4, 126.9, 128.8,
129.1, 129.3, 133.39, 133.43, 134.1, 143.6, 169.0.
2-Allyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless solid,
1
m.p. 88–90 °C (lit. 77–82 °C8 or 89–90 °C9); H NMR (400 MHz,
CDCl3): δ 4.37 (d, J = 6.0 Hz, 2H), 5.30 (d, J = 10.0 Hz, 1H), 5.44 (d,
J = 17.2 Hz, 1H), 5.96 (m, 1H), 7.84 (m, 2H), 7.92 (d, J = 7.2 Hz,
1H), 8.05 (d, J = 7.2 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 41.2,
119.7, 120.9, 125.1, 127.3, 130.5, 134.3, 134.7, 137.8, 158.5.
3-Allyloxy-1,2-benzisothiazole 1,1-dioxide: Colourless solid, m.p.
2-Isobutyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless
solid, m.p. 56–58 °C; H NMR (400 MHz, CDCl3): δ 1.02 (d, J =
1
6.4 Hz, 6H), 2.30 (m, 1H), 3.59 (d, J = 8.0 Hz, 2H), 7.85 (m, 2H), 7.93
(d, J = 7.2 Hz, 1H), 8.06 (d, J = 7.2 Hz, 1H). 13C NMR (100 MHz,
CDCl3): δ 20.0, 27.6, 46.6, 120.8, 125.1, 127.3, 134.2, 134.6, 137.6,
159.2; HRMS Calcd for C11H14NO3S [M+H]+: 240.0689; found:
240.0697.
3-Isobutyloxy-1,2-benzisothiazole 1,1-dioxide: Colourless solid,
m.p. 101–102 °C; 1H NMR (400 MHz, CDCl3): δ 1.07 (d, J = 6.8 Hz,
6H), 2.23 (m, 1H), 4.37 (d, J = 6.8 Hz, 2H), 7.74 (m, 3H), 7.87 (d,
J = 6.8 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 18.8, 27.6, 77.8,
121.8, 123.2, 127.0, 133.4, 134.0, 143.5, 169.2; HRMS Calcd for
C11H14NO3S [M+H]+: 240.0689; found: 240.0693.
1
139–140 °C (lit.8 140 °C); H NMR (400 MHz, CDCl3): δ 5.06 (d,
J = 6.0 Hz, 2H), 5.43 (d, J = 10.4 Hz, 1H), 5.52 (d, J = 17.2 Hz, 1H),
6.10 (m, 1H), 7.74 (m, 3H), 7.87 (d, J = 8.0 Hz, 1H). 13C NMR
(100 MHz, CDCl3): δ 72.2, 121.3, 121.8, 123.3, 126.9, 129.9, 133.4,
134.1, 143.6, 168.9.
2-Ethyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless solid,
1
m.p. 92–94 °C (lit.9 93.5–94.5 °C); H NMR (400 MHz, CDCl3):
δ 1.46 (t, J = 7.2 Hz, 3H), 3.86 (d, J = 7.2 Hz, 2H), 7.87 (m, 3H), 8.05
(d, J = 6.8 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 14.1, 34.7, 121.0,
125.2, 127.7, 134.4, 134.8, 138.0, 158.8.
2-Isopropyl-1,2-benzisothiazol-3(2H)-one 1,1-dioxide: Colourless
1
solid, m.p. 65–66 °C (lit.5 63–64 °C); H NMR (400 MHz, CDCl3):
2-(2-Phenylethyl)-1,2-benzisothiazol-3(2H)-one1,1-dioxide:Colour-
δ 1.62 (d, J = 7.2 Hz, 6H), 4.53 (m, 1H), 7.84 (m, 3H), 8.02 (d, J =
7.6 Hz, 1H). 13C NMR (100 MHz, CDCl3): δ 20.3, 47.1, 120.5, 124.8,
127.4, 134.1, 134.5, 137.9, 158.7.
1
less solid, m.p. 138–139 °C (lit.9 138–139 °C); H NMR (400 MHz,
CDCl3): δ 3.15 (t, J = 8.2 Hz, 2H), 4.00 (t, J = 8.2 Hz, 2H), 7.28 (m,